...
首页> 外文期刊>Metabolism: Clinical and Experimental >Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes.
【24h】

Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes.

机译:在两种遗传性肥胖模型中,游离和总瘦素血清水平以及可溶性瘦素受体水平:普拉德-威利和唐氏综合症。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Alterations in energy balance and feeding behavior and the subsequent high frequency of obesity are hallmarks of 2 chromosomal diseases: the Prader-Willi syndrome (PWS) and the Down syndrome (DS). Leptin, an important regulator of food intake and energy homeostasis, circulates in 2 forms: a free, therefore active, fraction and a fraction bound to the soluble leptin receptor, whose bioavailability consequently participates in the regulation of leptin action. To investigate the possible role of the free-bound leptin balance in the pathogenesis of obesity in PWS and DS, we enrolled 7 obese women with DS, 5 obese women with PWS, 7 obese women, and 7 normal-weight healthy control women. Basal hormonal concentrations, total and free leptin levels, and leptin receptors levels were measured in plasma samples obtained from the 4 groups. No significant differences were observed in the hormonal milieu. Women with DS exhibited lower total leptin concentrations (P<.01), comparable leptin receptor level and, therefore, lower free leptin values (P<.01) when compared with obese controls, then resembling the profile peculiar to normal-weight control women. At variance, subjects with PWS did not differ from obese controls regarding both leptin and leptin receptor levels. Our data suggest that, whereas subjects with PWS have a leptin assessment corresponding to their degree of obesity, subjects with DS may have a defect in the secretion of leptin that could at least partially account for this form of syndromal obesity.
机译:能量平衡和进食行为的改变以及随后的肥胖症高发是2种染色体疾病的标志:普拉德-威利综合症(PWS)和唐氏综合症(DS)。瘦素是食物摄取和能量稳态的重要调节剂,它以两种形式循环:游离的,因此有活性的馏分和与可溶性瘦素受体结合的馏分,其生物利​​用度因此参与了瘦素作用的调节。为了研究瘦素自由平衡在PWS和DS中肥胖发病机理中的可能作用,我们招募了7名肥胖的DS妇女,5名PWS的肥胖妇女,7名肥胖的妇女和7名正常体重的健康对照妇女。在从4组中获得的血浆样本中测量了基础激素浓度,总和游离瘦素水平以及瘦素受体水平。在荷尔蒙环境中未观察到显着差异。与肥胖对照者相比,DS患者的总瘦素浓度较低(P <.01),瘦素受体水平相当,因此游离瘦素值较低(P <.01),类似于正常体重对照者的特征。有差异的是,在瘦素和瘦素受体水平方面,患有PWS的受试者与肥胖对照组无差异。我们的数据表明,尽管PWS受试者的瘦素评估水平与其肥胖程度相对应,但是DS受试者的瘦素分泌可能存在缺陷,至少可以部分解释这种形式的肥胖症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号